{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T10:43:03Z","timestamp":1793270583705,"version":"4.5.0"},"reference-count":26,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100013733","name":"Ipsen Biopharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013733","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007052","name":"Memorial Sloan-Kettering Cancer Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007052","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013768","name":"Society of Interventional Radiology Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013768","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006775","name":"GE Healthcare","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006775","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jvir.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Vascular and Interventional Radiology"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.jvir.2025.03.006","type":"journal-article","created":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T19:46:02Z","timestamp":1741895162000},"page":"1160-1170","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Outcomes of Transarterial Hepatic Embolization versus Yttrium-90 Radioembolization for Treatment of Patients with Hepatocellular Carcinoma >7 cm"],"prefix":"10.1016","volume":"36","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2003-7930","authenticated-orcid":false,"given":"Sam Y.","family":"Son","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Velayati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2683-1171","authenticated-orcid":false,"given":"Ken","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3220-1360","authenticated-orcid":false,"given":"Brett","family":"Marinelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8461-0011","authenticated-orcid":false,"given":"Ruben","family":"Geevarghese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7278-1369","authenticated-orcid":false,"given":"Vlasios S.","family":"Sotirchos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Covey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James J.","family":"Harding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael I.","family":"D\u2019Angelica","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William R.","family":"Jarnagin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3127-9222","authenticated-orcid":false,"given":"Hooman","family":"Yarmohammadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jvir.2025.03.006_bib1","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1016\/j.jhep.2022.08.021","article-title":"Global burden of primary liver cancer in 2020 and predictions to 2040","volume":"77","author":"Rumgay","year":"2022","journal-title":"J Hepatol"},{"key":"10.1016\/j.jvir.2025.03.006_bib2","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1111\/liv.12818","article-title":"Global patterns of hepatocellular carcinoma management from diagnosis to death: the BRIDGE Study","volume":"35","author":"Park","year":"2015","journal-title":"Liver Int"},{"key":"10.1016\/j.jvir.2025.03.006_bib3","doi-asserted-by":"crossref","first-page":"4401","DOI":"10.2147\/CMAR.S177663","article-title":"Importance of tumor size at diagnosis as a prognostic factor for hepatocellular carcinoma survival: a population-based study","volume":"10","author":"Wu","year":"2018","journal-title":"Cancer Manag Res"},{"key":"10.1016\/j.jvir.2025.03.006_bib4","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1053\/j.gastro.2006.05.021","article-title":"Prospective cohort study of transarterial chemoembolization for unresectable hepatocellular carcinoma in 8510 patients","volume":"131","author":"Takayasu","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jvir.2025.03.006_bib5","doi-asserted-by":"crossref","first-page":"17","DOI":"10.21037\/cco-22-119","article-title":"Image-guided percutaneous locoregional therapies for hepatocellular carcinoma","volume":"12","author":"Chevallier","year":"2023","journal-title":"Chin Clin Oncol"},{"key":"10.1016\/j.jvir.2025.03.006_bib6","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/j.jvir.2008.02.013","article-title":"Transcatheter arterial embolization with only particles for the treatment of unresectable hepatocellular carcinoma","volume":"19","author":"Maluccio","year":"2008","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.jvir.2025.03.006_bib7","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1002\/hep.29691","article-title":"Institutional decision to adopt Y90 as primary treatment for hepatocellular carcinoma informed by a 1,000-patient 15-year experience","volume":"68","author":"Salem","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.jvir.2025.03.006_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jvir.2022.10.011","article-title":"Adverse event classification: clarification and validation of the Society of Interventional Radiology Specialty-Specific System","volume":"34","author":"Baerlocher","year":"2023","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.jvir.2025.03.006_bib9","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1097\/COC.0000000000000560","article-title":"Patterns of care and outcomes of definitive external beam radiotherapy and radioembolization for localized hepatocellular carcinoma: a propensity score-adjusted analysis","volume":"42","author":"Bitterman","year":"2019","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.jvir.2025.03.006_bib10","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.jvir.2024.09.005","article-title":"Comparison of the effectiveness of transarterial bland embolization and transarterial chemoembolisation for intermediate-stage hepatocellular carcinoma: a propensity score-matched study of 1,008 patients","volume":"36","author":"Zhang","year":"2025","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.jvir.2025.03.006_bib11","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1200\/JCO.2015.64.0821","article-title":"Randomized trial of hepatic artery embolization for hepatocellular carcinoma using doxorubicin-eluting microspheres compared with embolization with microspheres alone","volume":"34","author":"Brown","year":"2016","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jvir.2025.03.006_bib12","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1016\/j.jvir.2010.04.015","article-title":"Chemoembolization for the treatment of large hepatocellular carcinoma","volume":"21","author":"Miyayama","year":"2010","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.jvir.2025.03.006_bib13","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S1051-0443(07)61910-1","article-title":"Liver abscess after transcatheter oily chemoembolization for hepatic tumors: incidence, predisposing factors, and clinical outcome","volume":"12","author":"Song","year":"2001","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.jvir.2025.03.006_bib14","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1007\/s12032-015-0504-3","article-title":"Transarterial chemoembolization for huge hepatocellular carcinoma with diameter over ten centimeters: a large cohort study","volume":"32","author":"Xue","year":"2015","journal-title":"Med Oncol"},{"key":"10.1016\/j.jvir.2025.03.006_bib15","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/j.1365-2036.2006.02704.x","article-title":"Survival benefit of transcatheter arterial chemoembolization in patients with hepatocellular carcinoma larger than 10 cm in diameter","volume":"23","author":"Huang","year":"2006","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jvir.2025.03.006_bib16","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1007\/s00270-021-02777-6","article-title":"Comparison of chemoembolization, radioembolization, and transarterial ethanol ablation for huge hepatocellular carcinoma (\u2265 10 cm) in tumour response and long-term survival outcome","volume":"45","author":"Yu","year":"2022","journal-title":"Cardiovasc Intervent Radiol"},{"key":"10.1016\/j.jvir.2025.03.006_bib17","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.1002\/hep.31819","article-title":"Yttrium-90 radioembolization for the treatment of solitary, unresectable HCC: the LEGACY Study","volume":"74","author":"Salem","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.jvir.2025.03.006_bib18","doi-asserted-by":"crossref","first-page":"81","DOI":"10.2147\/JHC.S398434","article-title":"Efficacy and safety of combined ethanol-Lipiodol mixture and drug-eluting bead TACE for large HCC","volume":"10","author":"Chuang","year":"2023","journal-title":"J Hepatocell Carcinoma"},{"key":"10.1016\/j.jvir.2025.03.006_bib19","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1265959","article-title":"Effect of external beam radiation therapy versus transcatheter arterial chemoembolization for non-diffuse hepatocellular carcinoma (\u2265 5 cm): a multicenter experience over a ten-year period","volume":"14","author":"Su","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.jvir.2025.03.006_bib20","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1177\/030089161109700608","article-title":"High-dose radiotherapy with intensity-modulated radiation therapy for advanced hepatocellular carcinoma","volume":"97","author":"Kang","year":"2011","journal-title":"Tumori"},{"key":"10.1016\/j.jvir.2025.03.006_bib21","doi-asserted-by":"crossref","first-page":"4914","DOI":"10.3390\/cancers15204914","article-title":"The current evidence of intensity-modulated radiotherapy for hepatocellular carcinoma: a systematic review and meta-analysis","volume":"15","author":"Jang","year":"2023","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.jvir.2025.03.006_bib22","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s13014-020-01739-5","article-title":"Clinical outcome and pathologic correlation of stereotactic body radiation therapy as a bridge to transplantation for advanced hepatocellular carcinoma: a case series","volume":"16","author":"Wang","year":"2021","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.jvir.2025.03.006_bib23","first-page":"31","article-title":"Multidisciplinary assessment of tumor response after internal and external radiation therapy for hepatocellular carcinoma","volume":"10","author":"Mendiratta-Lala","year":"2024","journal-title":"Hepatoma Res"},{"key":"10.1016\/j.jvir.2025.03.006_bib24","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1136\/gutjnl-2017-315485","article-title":"Immune activation underlies a sustained clinical response to Yttrium-90 radioembolisation in hepatocellular carcinoma","volume":"68","author":"Chew","year":"2019","journal-title":"Gut"},{"key":"10.1016\/j.jvir.2025.03.006_bib25","doi-asserted-by":"crossref","first-page":"3650","DOI":"10.1158\/1078-0432.CCR-23-0581","article-title":"A phase I\/IIa trial of yttrium-90 radioembolization in combination with durvalumab for locally advanced unresectable hepatocellular carcinoma","volume":"29","author":"Lee","year":"2023","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jvir.2025.03.006_bib26","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2022-005457","article-title":"Nivolumab after selective internal radiation therapy for the treatment of hepatocellular carcinoma: a phase 2, single-arm study","volume":"10","author":"de la Torre-Al\u00e1ez","year":"2022","journal-title":"J Immunother Cancer"}],"container-title":["Journal of Vascular and Interventional Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S105104432500243X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S105104432500243X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,23]],"date-time":"2025-06-23T08:23:51Z","timestamp":1750667031000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S105104432500243X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":26,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["S105104432500243X"],"URL":"https:\/\/doi.org\/10.1016\/j.jvir.2025.03.006","relation":{},"ISSN":["1051-0443"],"issn-type":[{"value":"1051-0443","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Outcomes of Transarterial Hepatic Embolization versus Yttrium-90 Radioembolization for Treatment of Patients with Hepatocellular Carcinoma >7 cm","name":"articletitle","label":"Article Title"},{"value":"Journal of Vascular and Interventional Radiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jvir.2025.03.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 SIR, 2025","name":"copyright","label":"Copyright"}]}}